Robert B. Gerbing
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Neurology top 0.1%
- Neuroblastoma Research and Treatments
Papers in
- Hematology 179
- Acute Myeloid Leukemia Research 172
- Hematopoietic Stem Cell Transplantation 30
- Multiple Myeloma Research and Treatments 25
- Genetics 34
- Co-authors
- Katherine K. MatthayTodd A. AlonzoHiroyuki ShimadaDaniel O. StramRobert C. SeegerSoheil MeshinchiAlan S. GamisBeverly J. Lange
- Journals
- Blood (111 papers)Journal of Clinical Oncology (29 papers)Pediatric Blood & Cancer (26 papers)Cancer (12 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Robert B. Gerbing
233 papers receiving 10.8k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 3.9k
- Neurology 5.3k
- Cancer Research 2.1k
- Genetics 1.3k
- Oncology 2.1k
Countries citing papers authored by Robert B. Gerbing
This map shows the geographic impact of Robert B. Gerbing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Gerbing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Gerbing more than expected).
Fields of papers citing papers by Robert B. Gerbing
This network shows the impact of papers produced by Robert B. Gerbing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Gerbing. The network helps show where Robert B. Gerbing may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert B. Gerbing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 57 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 39 | |
| 7 | 2017 | 20 | |
| 8 | 2017 | 10 | |
| 9 | 2017 | 1 | |
| 10 | 2015 | 20 | |
| 11 | 2015 | 42 | |
| 12 | 2015 | 41 | |
| 13 | Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531 Hit paper breakdown → | 2014 | 313 |
| 14 | 2013 | 42 | |
| 15 | 2013 | 32 | |
| 16 | 2013 | 11 | |
| 17 | 2003 | 173 | |
| 18 | 2001 | 140 | |
| 19 | 2001 | 98 | |
| 20 | 1999 | 314 |
About Robert B. Gerbing
Robert B. Gerbing is a scholar working on Hematology, Genetics, Neurology, Public Health, Environmental and Occupational Health and Cancer Research, having authored 239 papers that have together received 11.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (172 papers), Acute Lymphoblastic Leukemia research (75 papers), Neuroblastoma Research and Treatments (43 papers), Hematopoietic Stem Cell Transplantation (30 papers), Neutropenia and Cancer Infections (30 papers), Multiple Myeloma Research and Treatments (25 papers), Cancer therapeutics and mechanisms (21 papers) and Protein Degradation and Inhibitors (21 papers). The work is most often cited by research in Hematology (3.9k citations), Neurology (5.3k citations), Cancer Research (2.1k citations), Genetics (1.3k citations) and Oncology (2.1k citations). Robert B. Gerbing has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Katherine K. Matthay, Todd A. Alonzo, Hiroyuki Shimada, Daniel O. Stram, Robert C. Seeger, Soheil Meshinchi, Alan S. Gamis, Beverly J. Lange, Garrett M. Brodeur and John N. Lukens. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.